South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

organon south africa (pty) ltd - inhaler - see ingredients - each unit dose contains mometasone furoate 400,0 ug

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أداتكو - adatco drug store - mometasone furoate 400 mcg - 400 mcg

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

city medical store - sole proprietorship l.l.c belgium - 60 metered actuations twisthaler - inhaler - 200mcg/actuation - respiratory system-corticosteroids

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

city medical store - sole proprietorship l.l.c belgium - 60 metered actuations twisthaler - inhaler - 400mcg/actuatuion - respiratory system-corticosteroids

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

organon - mometasone furoate - white powder for meted dose inhaler, (container) white, (lower part) gray

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

organon - mometasone furoate - white powder for meted dose inhaler, (container) white, (lower part) pink

United States - English - NLM (National Library of Medicine)

a-s medication solutions - mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8), formoterol fumarate (unii: w34shf8j2k) (formoterol - unii:5zz84gcw8b) - mometasone furoate 200 ug - dulera is indicated for the twice-daily treatment of asthma in patients 12 years of age and older. dulera should be used for patients not adequately controlled on a long-term asthma-control medication such as an inhaled corticosteroid (ics) or whose disease warrants initiation of treatment with both an ics and long-acting beta2 -adrenergic agonist (laba). important limitation of use: - dulera is not indicated for the relief of acute bronchospasm. dulera is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. dulera is contraindicated in patients with known hypersensitivity to mometasone furoate, formoterol fumarate, or any of the ingredients in dulera [see warnings and precautions (5.10)] . risk summary there are no randomized clinical studies of dulera, mometasone furoate, or formoterol fumarate in pregnant women. there are clinical considerations with the use of dulera in pregnant women [see clinical considerations] . animal

Canada - English - Health Canada

organon canada inc. - mometasone furoate; formoterol fumarate dihydrate - aerosol, metered dose - 50mcg; 5mcg - mometasone furoate 50mcg; formoterol fumarate dihydrate 5mcg - selective beta 2-adrenergic agonists

Canada - English - Health Canada

organon canada inc. - mometasone furoate; formoterol fumarate dihydrate - aerosol, metered dose - 100mcg; 5mcg - mometasone furoate 100mcg; formoterol fumarate dihydrate 5mcg - selective beta 2-adrenergic agonists

Canada - English - Health Canada

organon canada inc. - mometasone furoate; formoterol fumarate dihydrate - aerosol, metered dose - 200mcg; 5mcg - mometasone furoate 200mcg; formoterol fumarate dihydrate 5mcg - selective beta 2-adrenergic agonists